TGFB1 and Myocardial fibrosis: Myocardial fibrosis is an important therapeutic target in HF cases 113, and WWP2 represents a regulator of TGFβ/SMAD signalling, which has critical functions in the activation and fibrosis of cardiac fibroblasts.